Managing gout: how is it different in patients with chronic kidney disease?

Cleve Clin J Med. 2010 Dec;77(12):919-28. doi: 10.3949/ccjm.77a.09080.

Abstract

Many patients with gout have comorbidities, including hypertension and chronic kidney disease (CKD). The goals when treating gout are no different in these patients, but the choice and dosage of drugs may need to be modified.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Adrenocorticotropic Hormone / adverse effects
  • Adrenocorticotropic Hormone / therapeutic use
  • Allopurinol / adverse effects*
  • Allopurinol / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Colchicine / adverse effects
  • Colchicine / therapeutic use
  • Comorbidity
  • Disease Progression
  • Febuxostat
  • Gout / drug therapy*
  • Gout Suppressants / adverse effects*
  • Gout Suppressants / therapeutic use
  • Humans
  • Kidney Failure, Chronic / pathology*
  • Risk Factors
  • Thiazoles / adverse effects*
  • Thiazoles / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Gout Suppressants
  • Thiazoles
  • Febuxostat
  • Allopurinol
  • Adrenocorticotropic Hormone
  • Colchicine